Intrinsic Value of S&P & Nasdaq Contact Us

Ascletis Pharma Inc. ASCLF OTC

Other OTC • Healthcare • Biotechnology • CN • USD

SharesGrow Score
31/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ASCLF

Ascletis Pharma Inc. (ASCLF) has a market capitalization of $2.22B and trades at $2.10. The 52-week range is 0.6217-2.29.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7, Earnings Per Share (EPS) of $-0.30, annual revenue of $1.28M.

The stock has a beta of 0.59, operates in the Healthcare sector.

Trading Data
Current Price$2.10
52-Week Range0.6217-2.29
Volume450
Avg Volume (30D)895
Market Cap$2.22B
Beta (1Y)0.59
Company
IPO Date2019-11-19
Employees231
CEOJinzi Jason Wu
CountryCN
ExchangeOther OTC
CurrencyUSD
ISINKYG0520K1094
Income (Latest Year)
Revenue$1.28M
Gross Profit$735K
EBITDA$-280.24M
Operating Income$-382.26M
Net Income$-300.94M
EPS$-0.30
EPS Diluted$-0.30
Shares Outstanding$1B
Balance Sheet (Latest Year)
Total Assets$2.12B
Current Assets$1.97B
Cash & ST Investments$1.95B
Total Liabilities$158.41M
Total Debt$7.63M
Net Debt$-858.1M
Total Equity$1.97B
Debt / Equity0.00
Valuation Ratios
P/E Ratio-7
P/S Ratio1727.38
P/B Ratio1.13
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message